ReviewMediterranean journal of hematology and infectious diseases2025
How First-Line Therapy is Changing in non-Transplant Eligible Multiple Myeloma Patients.
Francesca Fazio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it